Impacts of Different ART Regimens on Lipid Metabolism in People Living With HIV

Efficacy of BIC/F/TAF Versus Standard of Care in the Treatment of New HIV Infection Diagnoses in the Context of 'Test and Treat'

NCT04653194 ·Status: COMPLETED ·Phase: PHASE3

HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)

NCT00192660 ·Status: COMPLETED ·Phase: PHASE4

Nevirapine vs Ritonavir-boosted Lopinavir in ART Naive HIV-infected Adults in a Resource Limited Setting

NCT01772940 ·Status: COMPLETED ·Phase: PHASE4

Early Metabolic Effects of Antiretroviral Drugs in Healthy volUnteers: a Phase 2 Randomized Study

NCT05652478 ·Status: RECRUITING ·Phase: PHASE2

Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug Therapy

NCT00109603 ·Status: COMPLETED ·Phase: NA

A Comparison of Body Fat Distribution in HIV-1 Infected Patients Receiving, Since the Beginning and for at Least Two Years, an Antiretroviral Therapy Based on Efavirenz or Lopinavir/Ritonavir Combined With Tenofovir + Emtricitabine or Lamivudine

NCT01159743 ·Status: COMPLETED

Optimising Metabolic Management for People With Human Immunodeficiency Virus (HIV) on Integrase Based Antiretroviral Therapy (ART)

NCT06317051 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

PREventing Progression of Adipose Tissue Redistribution

NCT00389194 ·Status: COMPLETED ·Phase: PHASE4

Raltegravir Therapy for Women With HIV and Fat Accumulation

NCT00656175 ·Status: COMPLETED ·Phase: PHASE2

Reducing Antiretroviral Treatments

NCT04051970 ·Status: UNKNOWN ·Phase: PHASE3

ART Drug Dosage Adjustment in HIV-infected Population

NCT02632474 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate Switching From a Regimen of Two Nucleos(t)Ide Reverse Transcriptase Inhibitors (NRTI) Plus a Third Agent to a Fixed Dose Combination (FDC) of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF), in Virologically-Suppressed, HIV-1 Infected African American Participants

NCT03631732 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Efficacy and Safety of a Rilpivarine-based Antiretroviral Tratment Regimen in HIV- Infected Patients With Liver Metabolic Disease Who Maintain Udetectable HIV Viral Load

NCT05898841 ·Status: COMPLETED ·Phase: PHASE4

DTG/3TC vs. BIC/FTC/TAF Maintenance Therapy in People Living With HIV:

NCT04884139 ·Status: COMPLETED ·Phase: PHASE4

Metabolic Impact Assessment of Tenofovir Disoproxil Fumarate on Non-HIV-1 Infected Healthy Adult Male Volunteers

NCT00648817 ·Status: COMPLETED ·Phase: PHASE4

Trial To Assess The Lipid-Lowering Effect Of Adding Tenofovir/Emtricitabine Co-Formulation Vs Placebo To Hiv-1-Infected Subjects With Dyslipidemia And Sustained Viral Load Suppression Under Monotherapy With Ritonavir-Boosted Protease Inhibitors

NCT01458977 ·Status: COMPLETED ·Phase: PHASE4

Duration of Dual Antiretroviral Therapy in Virologically Suppressed People Living With HIV and Factors Associated With Switching to Tritherapy : a Real-life Cohort

NCT06107140 ·Status: COMPLETED

Doravirine and Weight Gain in Antiretroviral Naive

NCT05457530 ·Status: WITHDRAWN ·Phase: PHASE3

Changes in Lipids and Lipoproteins in HIV Infected Women After Switch From Protease Inhibitor to Raltegravir

NCT02097108 ·Status: COMPLETED ·Phase: PHASE2

Switching TDF/FTC/EFV to TDF/FTC/RPV VS Continuing TDF/FTC/EFV in HIV Patients With Complete Virological Suppression

NCT03251690 ·Status: COMPLETED ·Phase: NA

Chidamide in Combination With ART for Reactivation of the Latent HIV-1 Reservoir

NCT02902185 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

DOR/TDF/3TC COmpared With BIC/FTC/TAF in ART-Naïve People Living With HIV and Overweight or Obesity

NCT07075146 ·Status: RECRUITING ·Phase: PHASE3

The Compartmental Biology of HIV in the Male Genital Tract

NCT02638493 ·Status: COMPLETED

Same-Day HIV Testing and Treatment Initiation to Improve Retention in Care

NCT01900080 ·Status: UNKNOWN ·Phase: NA

A Pilot Study of Triple NtRTI/NsRTI Therapy in Antiretroviral Naive HIV-1 Infected Patients

NCT00199121 ·Status: UNKNOWN ·Phase: PHASE4